$BIRK

Birkenstock reported a 16% revenue increase to EUR 2.1 billion in fiscal 2025, driven by limited supply and expanded product range. Closed-toe styles accounted for 38% of revenue, up 500 basis points. The company plans controlled capacity expansion, with guidance for 13-15% constant currency revenue growth in fiscal 2026, citing currency and capacity as main risks.

Williams Trading downgraded Birkenstock (NYSE:BIRK) to Sell, lowering its price target to $27 from $39, citing concerns about meeting fiscal 2028 targets. The stock has fallen 12.3% year-to-date. Other analysts maintain positive ratings, with JPMorgan and UBS setting higher price targets. Birkenstock's management remains optimistic despite broader retail sector declines.

BTIG notes mixed promotional activity among footwear brands in September 2026. Birkenstock, Hoka, Vans, and Boot Barn increased promotions, while On Running, Steve Madden, and Ugg reduced them. Analyst Janine Stichter projects varied gross margin impacts for these brands, citing factors like DTC growth, freight costs, and tariffs. UBS reports a 3.5% year-over-year price increase for softgoods, with Birkenstock showing the largest promotion increase.

Birkenstock stock rose 6.3% to $33.80 after JPMorgan reaffirmed its Overweight rating and $58 price target, citing management's 13-15% revenue growth guidance. The stock was near its 52-week low, and JPMorgan projects 35% FY2027 EPS growth, above consensus. The broader market also gained, with the S&P 500 up 0.4% and the Dow Jones up 0.8%.

Michael Burry, known for predicting the 2008 financial crisis, is increasing short positions on Micron Technology, Nebius Group, SOXX ETF, and Palantir, betting against the memory chip industry. He cites increasing Chinese production capacity and potential future oversupply. Micron's forward free cash flow has surged to $130 billion. Burry also added to long positions in QXO, Build-A-Bear, Sprouts, Birkenstock, and MercadoLibre.

Michael Burry, known for his 'Big Short' bet, has increased his short position in Micron Technology (MU) and other semiconductor-related investments, citing concerns about memory producers' high valuations. He also shorted Applied Materials (AMAT) and Lam Research (LRCX). Micron's stock rose 5% to $1,096.16 on Tuesday, with a 14% gain in September. Burry's views are based on market trends and comments from industry leaders, but he acknowledges the difficulty in timing market tops.

Michael Burry increased short positions in Micron (MU), Nebius (NBIS), SOXX ETF, and Palantir (PLTR). He also added long positions in QXO (QXO), Build-A-Bear (BBW), Sprouts (SFM), Birkenstock (BIRK), and MercadoLibre (MELI). Micron is expected to report Q4 earnings on Sept. 30, with analysts forecasting EPS of $31.30 and revenue of $50.62B, according to Benzinga.

Birkenstock Holding plc (NYSE:BIRK) reported Q3 revenue of €720M, up 13%, exceeding expectations. Adjusted EPS was €0.74, slightly below consensus. The company raised full-year guidance, targeting 15% revenue growth and €710M in adjusted EBITDA. Shares rose up to 20% on August 13. Strength was driven by full-price demand from affluent buyers, with all regions showing growth. The company also executed a €230M share buyback program. Management noted currency and tariff pressures on margins.

Famous Footwear, owned by Caleres, reported a 6.3% net sales decline in Q2 2026, with comparable sales down 5.9%. CEO Jay Schmidt attributed this to weaker demand for lifestyle athletic shoes and a late back-to-school start. However, fashion footwear brands like Jordan, Birkenstock, and Brooks performed well, with fashion comps outperforming athletic by over 10 points. The company plans to expand fashion assortment and increase inventory investment to support demand, aiming for sales improvement

BMO Capital initiated coverage on Birkenstock (NYSE:BIRK) with a Market Perform rating and a $35.00 price target. The stock has fallen 16.9% year-to-date, trading near its 52-week low. BMO acknowledges Birkenstock's strong brand and supply chain but expresses caution due to maturing growth in key markets. Analysts have revised earnings downward, though revenue grew 11.8% over the last year. Recent developments include a secondary share offering and price target increases from other analysts.